Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
More corporates waiting to pounce, but blackouts and Easter set to hamper supply -
Saudi pharmacy chain Nahdi has started trading on the Tadawul following the largest IPO in the Kingdom since December 2019
-
GSK’s consumer spin-off roadshows amid calm after Fed and BofE meetings
-
Major shareholder reduces stake in Spanish pharmaceuticals company
-
Saudi Arabia’s IPO market is thriving amid the turmoil caused by Russia’s invasion of Ukraine
-
Boston Scientific plans four tranche deal as European issuers hang back
